• Je něco špatně v tomto záznamu ?

N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation

K. Hulíková, V. Benson, J. Svoboda, P. Šíma, A. Fišerová

. 2009 ; 9 (6) : 792-799.

Jazyk angličtina Země Nizozemsko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11017195

N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer (GlcNAc8) was shown previously to exhibit binding affinity to the rat recombinant NKR-P1 molecule (known in mice also as NK1.1) and to induce NK cell-mediated cytotoxicity. In this study, we investigated whether GlcNAc8 modulates antibody formation as activated NK cells were reported to participate in its regulation. C57BL/6 mice treated with GlcNAc8 and intact controls were immunized either with sheep red blood cells (SRBCs), 2,4-dinitrophenylated-lipopolysaccharide (DNP-LPS) or keyhole limpet hemocyanin (KLH) for evaluation of splenic antibody forming cell counts and serum immunoglobulin (Ig) levels. In vitro Ig formation was determined using supernatants of spleen mononuclear cells (SMCs) and CD49b or NK1.1-depleted SMC subpopulations. Serum antigen-specific IgG2a levels were also measured in DBA/2 and BALB/c mice (NK1.1-negative mouse strains on the basis of flow cytometric analysis) which possess different Nkr-p1c gene form than C57BL/6 ones. A significant increase in anti-SRBC IgG forming cells, serum levels of anti-KLH as well as anti-DNP IgG and IgG2a was observed after GlcNAc8 administration in C57BL/6 mice. IgM levels in supernatants of SMCs stimulated in vitro simultaneously with DNP-LPS and GlcNAc8 were significantly mounted compared with supernatants of SMCs primed with the antigen alone, but this enhancement was blocked after depletion of CD49b-positive or NK1.1-positive cells. In DBA/2 and BALB/c mice, GlcNAc8 influenced neither serum levels of anti-KLH nor anti-DNP IgG2a. These results indicate that GlcNAc8-induced upregulation of antibody formation is triggered by NK cell stimulation and depends on expressed NKR-P1 isoforms, particularly NKR-P1C.

000      
04163naa 2200601 a 4500
001      
bmc11017195
003      
CZ-PrNML
005      
20121129092920.0
008      
110629s2009 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Hulíková, Katarína. $7 _AN043256
245    10
$a N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer modulates antibody formation via natural killer cell activation / $c K. Hulíková, V. Benson, J. Svoboda, P. Šíma, A. Fišerová
314    __
$a Institute of Microbiology, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic.
520    9_
$a N-Acetyl-D-glucosamine-coated polyamidoamine dendrimer (GlcNAc8) was shown previously to exhibit binding affinity to the rat recombinant NKR-P1 molecule (known in mice also as NK1.1) and to induce NK cell-mediated cytotoxicity. In this study, we investigated whether GlcNAc8 modulates antibody formation as activated NK cells were reported to participate in its regulation. C57BL/6 mice treated with GlcNAc8 and intact controls were immunized either with sheep red blood cells (SRBCs), 2,4-dinitrophenylated-lipopolysaccharide (DNP-LPS) or keyhole limpet hemocyanin (KLH) for evaluation of splenic antibody forming cell counts and serum immunoglobulin (Ig) levels. In vitro Ig formation was determined using supernatants of spleen mononuclear cells (SMCs) and CD49b or NK1.1-depleted SMC subpopulations. Serum antigen-specific IgG2a levels were also measured in DBA/2 and BALB/c mice (NK1.1-negative mouse strains on the basis of flow cytometric analysis) which possess different Nkr-p1c gene form than C57BL/6 ones. A significant increase in anti-SRBC IgG forming cells, serum levels of anti-KLH as well as anti-DNP IgG and IgG2a was observed after GlcNAc8 administration in C57BL/6 mice. IgM levels in supernatants of SMCs stimulated in vitro simultaneously with DNP-LPS and GlcNAc8 were significantly mounted compared with supernatants of SMCs primed with the antigen alone, but this enhancement was blocked after depletion of CD49b-positive or NK1.1-positive cells. In DBA/2 and BALB/c mice, GlcNAc8 influenced neither serum levels of anti-KLH nor anti-DNP IgG2a. These results indicate that GlcNAc8-induced upregulation of antibody formation is triggered by NK cell stimulation and depends on expressed NKR-P1 isoforms, particularly NKR-P1C.
590    __
$a bohemika - dle Pubmed
650    _2
$a acetylglukosamin $x analogy a deriváty $x farmakologie $x chemie $7 D000117
650    _2
$a zvířata $7 D000818
650    _2
$a tvorba protilátek $x účinky léků $7 D000917
650    _2
$a buňky produkující protilátky $x imunologie $x účinky léků $7 D000921
650    _2
$a antigeny Ly $x imunologie $x metabolismus $7 D000950
650    _2
$a B-lymfocyty $x imunologie $x účinky léků $7 D001402
650    _2
$a dendrimery $x farmakologie $x chemie $7 D050091
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hemokyanin $x imunologie $7 D006433
650    _2
$a imunoglobuliny $x krev $7 D007136
650    _2
$a imunologické faktory $x farmakologie $x chemie $7 D007155
650    _2
$a buňky NK $x imunologie $x účinky léků $7 D007694
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši inbrední DBA $7 D008811
650    _2
$a lektinové receptory NK-buněk - podrodina B $x imunologie $x metabolismus $7 D055651
650    _2
$a NKT buňky $x imunologie $x účinky léků $7 D055611
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Benson, Veronika, $d 1976- $7 xx0122082
700    1_
$a Svoboda, Jan $7 xx0094349
700    1_
$a Šíma, Petr, $d 1942- $7 jk01122950
700    1_
$a Fišerová, Anna $7 xx0074790
773    0_
$t International Immunopharmacology $w MED00006034 $g Roč. 9, č. 6 (2009), s. 792-799
910    __
$a ABA008 $b x $y 2
990    __
$a 20110720103006 $b ABA008
991    __
$a 20121129092948 $b ABA008
999    __
$a ok $b bmc $g 864195 $s 726993
BAS    __
$a 3
BMC    __
$a 2009 $x MED00006034 $b 9 $c 6 $d 792-799 $m International immunopharmacology $n Int Immunopharmacol
LZP    __
$a 2011-3B09/BBjvme

Najít záznam